Restraining the Proliferation of Acute Lymphoblastic Leukemia Cells by Genistein through Up-regulation of B-cell Translocation Gene-3 at Transcription Level
DOI:
https://doi.org/10.31661/gmj.v8i.1229Keywords:
Acute Lymphoblastic Leukemia, Anti-Proliferation, B-cell Translocation Gene-3, GenisteinAbstract
Background: Acute lymphoblastic leukemia (ALL) is a highly prevalent pediatric cancer accounting for approximately 78% of leukemia cases in patients younger than 15 years old. Different studies have demonstrated that B-cell translocation gene 3 (BTG3) plays a suppressive role in the progress of different cancers. Genistein is considered a natural and biocompatible compound and a new anti-cancer agent. In this study, we evaluate the effect of genistein on BTG3 expression and proliferation of ALL cancer cells. Materials and Methods: ALL cell lines (MOLT4, MOLT17, and JURKAT) were cultured in standard conditions. Cytotoxicity of genistein was detected using MTT assay. The cells were treated with different concentrations of genistein (10, 25, 40, and 55μM) for 24, 48, and 72 hours, and then cell viability and growth rate were measured. The quantitative real-time polymerase chain reaction was applied to investigate the effect of genistein on BTG3 expression. Results: The percentage of vital cells treated with genistein significantly decreased compared to the non-treated cells, showed an inverse relationship with an increasing genistein concentration. The present study suggests a dose of 40μM for genistein as a potent anticancer effect. Genistein could elevate BTG3 for 1.7 folds in MOLT4 and JURKAT and 2.7 folds in MOLT17 cell lines at transcription level conveged with 60 to 90% reduction in the proliferation rate of cancer cells. Conclusion: Up-regulation of BTG3 as a tumor suppressor gene can be induced by genistein. It seems that BTG3 reactivation can be introduced as another mechanism of anti-proliferative effect of genistein and could be considered as a retardant agent candidate against hematopoietic malignancy.[GMJ.2019;8:e1229]
References
Stiller C, Parkin D. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull. 1996; 52(4): 682-703. https://doi.org/10.1093/oxfordjournals.bmb.a011577PMid:9039726 Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. The Lancet. 2013; 381(9881): 1943-1955. https://doi.org/10.1016/S0140-6736(12)62187-4 Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004; 350(15):1535-48 https://doi.org/10.1056/NEJMra023001PMid:15071128 Nguyen K, Devidas M, Cheng SC, La M, Raetz EA, Carroll WL, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia. 2008; 22(12):2142-50. https://doi.org/10.1038/leu.2008.251PMid:18818707 PMCid:PMC2872117 Hunger SP, Mullighan CG. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood. 2015; 125(26):3977-87. https://doi.org/10.1182/blood-2015-02-580043PMid:25999453 PMCid:PMC4481590 Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest. 2012; 122(10): 3398-3406. https://doi.org/10.1172/JCI61269PMid:23023710 PMCid:PMC3461904 Jones PA, Laird PW. Cancer-epigenetics comes of age. Nat Genet. 1999; 21(2):163-7. https://doi.org/10.1038/5947PMid:9988266 Cortes U, Moyret-Lalle C, Falette N, Duriez C, Ghissassi FE, Barnas C, et al. BTG gene expression in the p53â€dependent andâ€independent cellular response to DNA damage. Mol Carcinog. 2000; 27(2):57-64. https://doi.org/10.1002/(SICI)1098-2744(200002)27:2 Cheng YC, Lin TY, Shieh SY. Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1. Proc Natl Acad Sci U S A. 2013; 110(15):5993-98. https://doi.org/10.1073/pnas.1220635110PMid:23533280 PMCid:PMC3625301 Ou Y-H, Chung P-H, Sun T-P, Shieh S-Y. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J. 2007; 26(17):3968-80. https://doi.org/10.1038/sj.emboj.7601825PMid:17690688 PMCid:PMC1994125 Majid S, Altaf AD, Ardalan EA, Hiroshi H, Kazumori K, Varahram S, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009; 30(4):662-70. https://doi.org/10.1093/carcin/bgp042PMid:19221000 PMCid:PMC2664457 Yoneda M, Suzuki T, Nakamura T, Ajima R, Yoshida Y, Kakuta S, et al. Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma. Cancer Sci. 2009; 100(2):225-232. https://doi.org/10.1111/j.1349-7006.2008.01030.xPMid:19068083 Yamamoto N, Uzawa K, Miya T, Watanabe T, Yokoe H, Shibahara T, et al. Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus. Br J Cancer. 2001; 84(6):754-62. https://doi.org/10.1054/bjoc.2000.1656PMid:11259088 PMCid:PMC2363813 Lin T, Cheng YC, Yang HC, Lin WC, Wang CC, Lai PL, et al. Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16INK4a signaling axis. Oncogene. 2012; 31(27):3287-97. https://doi.org/10.1038/onc.2011.491PMid:22020331 Chen X, Chen G, Cao X, Zhou Y, Yang T, Wei S. et al., Downregulation of BTG3 in non-small cell lung cancer. Biochem Biophys Res Commun. 2013; 437(1):173-8. https://doi.org/10.1016/j.bbrc.2013.06.062PMid:23810394 Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, Kawamoto K, et al. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene Bâ€Cell translocation gene 3 in prostate cancer. Cancer. 2010; 116(1):66-76. https://doi.org/10.1002/cncr.24662PMid:19885928 PMCid:PMC3954042 Deng B, Zhao Y, Gou W, Chen S, Mao X, Takano Y, Zheng H. Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma. Tumour Biol. 2013; 34(5):2617-24. https://doi.org/10.1007/s13277-013-0811-2PMid:23657964 PMCid:PMC3785705 Lv Z, Zou H, Peng K, Wang J, Ding Y, Li Y, et al., The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma. PloS one. 2013; 8(10):77473. https://doi.org/10.1371/journal.pone.0077473PMid:24147003 PMCid:PMC3798399 Yu J, Zhang Y, Qi Z, Kurtycz D, Vacano G. Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells. Gene Expr. 2007; 14(3):173-182. Putnik M, Zhao C, Gustafsson JÃ…, Dahlman-Wright K. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells. Biochem Biophys Res Commun. 2012; 426(1):26-32. https://doi.org/10.1016/j.bbrc.2012.08.007PMid:22902638 Chen WF, Huang MH, Tzang CH, Yang M, Wong MS. Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim Biophys Acta Mol Basis Dis. 2003; 1638(2):187-96. https://doi.org/10.1016/S0925-4439(03)00082-6 Peterson G, Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 1996; 7(10):1345-51. Pagliacci M, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer. 1994; 30(11):1675-82. https://doi.org/10.1016/0959-8049(94)00262-4 Nikbakht M, Jha A.K, Malekzadeh3 K, Askari M, Mohammadi S, Marwaha R.K, Kaul D, Kaur J.Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among north indian population. Exp Oncol. 2017; 39(1):57-64 https://doi.org/10.31768/2312-8852.2017.39(1):57-64 Xiaoxia Liu X, Lianhua Y, Jingxin D, Hongyan J, Youji F. Genistein inhibits placental choriocarcinoma cell line JAR invasion through ERβ/MTA3/Snail/E-cadherin pathway. Oncol Lett. 2011; 2(5): 891-897. Yong W, He W, Wei Z, Chen S, Chen S, Peng X, et al. Genistein sensitizes bladder cancer cells to hcpt treatment in vitro and in vivo via atm/nf-kb/ikk pathway-induced apoptosis. PLOS ONE. 2013; 8(1): e50175. https://doi.org/10.1371/journal.pone.0050175PMid:23365634 PMCid:PMC3554754 Yu D, Shin HS, Lee YS, Lee D, Kim S, Lee YC. Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1. Oncol Rep. 2014, 31(2):673-8. https://doi.org/10.3892/or.2013.2893PMid:24297371 Zhang S, Wang Y, Chen Z, Kim S, Iqbal S, Chi A. Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells. Prostate. 2013,73(15):1681-9. https://doi.org/10.1002/pros.22705PMid:23999913 PMCid:PMC4499861 Raghu Nadhanan R, Skinner J, Chung R, Su YW, Howe PR, Xian CJ. Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats. PloS on. 2013, 8(8):e71592. https://doi.org/10.1371/journal.pone.0071592PMid:23951199 PMCid:PMC3741109 Huang W, Wan C, Luo Q, Huang Z. Genistein-inhibited cancer stem cell-like properties and reduced chemoresistance of gastric cancer. Int J Mol Sci. 2014,15(3):3432-43. https://doi.org/10.3390/ijms15033432PMid:24573253 PMCid:PMC3975346 Yan GR, Zou FY, Dang BL, Zhang Y, Yu G, Liu X. Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study. Proteomics. 2012, 12(14):2391-9. https://doi.org/10.1002/pmic.201100652PMid:22887948 Liu YL, Zhang GQ, Yang Y, Zhang CY, Fu RX, Yang YM, et al. Genistein induces G2/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression. Nutr Cancer. 2013, 65(7):1034-41. https://doi.org/10.1080/01635581.2013.810290PMid:24053672 Ko KP, Park SK, Park B, Yang JJ, Cho LY, Kang C. Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev. 2010, 19(5):1292-300. https://doi.org/10.1158/1055-9965.EPI-09-1004PMid:20447921 Carlo-Stella C1, Regazzi E, Garau D, Mangoni L, Rizzo MT, Bonati A, et al. Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. Br J Haematol. 1996, 93(3):551-7. https://doi.org/10.1046/j.1365-2141.1996.d01-1694.xPMid:8652372 Li Y, Upadhyay S, Bhuiyan M, Sarkar FH. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 1999, 18(20): 3166 - 72. https://doi.org/10.1038/sj.onc.1202650PMid:10340389 Zhang LL, Li L, Wu DP, Fan JH, Li X, Wu KJ, et al. A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells. Acta Pharmacol Sin. 2008; 29(9): 1060-8. https://doi.org/10.1111/j.1745-7254.2008.00831.xPMid:18718175 Howard L, Parnes MD, William D, Pharm D. Chemoprevention in Prostate Cancer. Pharmacotherapy. 2006; 57: 1533. https://doi.org/10.1592/phco.26.10.1533PMid:16999665 Severson RK, Nomura AM, Grove JS, Stemmermann GN. A Prospective Study of Demographics, Diet, and Prostate Cancer among Men of Japanese Ancestry in Hawaii. Cancer Res. 1989; 49(7): 1857-60. Maria R, Carmela S, Idolo T, Gian Luigi R. Phytochemicals in Cancer Prevention and Therapy: Truth or Dare?. Toxins. 2010; 2(4): 517-51. https://doi.org/10.3390/toxins2040517PMid:22069598 PMCid:PMC3153217 Carmela S, Gian Luigi R, Ilkay Erdogan O, Solomon H, Maria D, Antoni S, et al. Genistein and Cancer: Current Status, Challenges, and Future Directions. Adv Nutr. 2015; 6(4): 408-19. https://doi.org/10.3945/an.114.008052PMid:26178025 PMCid:PMC4496735 Russo M, Gian Luigi A, Daglia M, DeviKasi P, Ravi S, Nabavi SF, et al. Understanding genistein in cancer: The ''good" and the ''bad" effects: A review. Food Chem. 2016; 196: 589-600. https://doi.org/10.1016/j.foodchem.2015.09.085PMid:26593532 Henrique B, Eduardo P, Eduardo L, Nathalia C, Rodrigo A, Carina C, et al. Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer. Prostate Cancer. 2013; 2013: 23. https://doi.org/10.1155/2013/920612PMid:23738079 PMCid:PMC3657461 Weiqi D, Lei H, Chunlei L, Shumei W, Ping C, Yan Z, et al. Genistein Inhibits Hepatocellular Carcinoma Cell Migration by Reversing the Epithelial-Mesenchymal Transition: Partial Mediation by the Transcription Factor NFAT1. Mol Carcinog. 2013; 54(4): 301-311. https://doi.org/10.1002/mc.22100PMid:24243709 Setchell K, Borriello SP, Hulme P, Kirk DN, Axelson M., Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr. 1984; 40(3):569-78. https://doi.org/10.1093/ajcn/40.3.569PMid:6383008 Barnes S, Grubbs C, Setchell KD, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res. 1990. 347: 239. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest. 1990; 50(sup201):3-23. https://doi.org/10.1080/00365519009085798 Fritz WA, Coward L, Wang J, Lamartiniere CA. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis. 1998; 19(12):2151-8. https://doi.org/10.1093/carcin/19.12.2151PMid:9886571 Peterson G, Barnes S., Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate. 1993; 22(4):335-5. https://doi.org/10.1002/pros.2990220408PMid:8497428 Constantinou A, Kiguchi K, Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 1990; 50(9):2618-24. Lamartiniere CA. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr. 2000; 71(6):1705-7. https://doi.org/10.1093/ajcn/71.6.1705SPMid:10837323 Xia J, Duan Q, Ahmad A, Bao B, Banerjee S, Shi Y, et al. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr Drug Targets. 2012; 13(14):1750-6. https://doi.org/10.2174/138945012804545597PMid:23140286 http://www.uniprot.org/uniprot/Q14201 https://www.qiagen.com/us/shop/genes-and-pathways/pathway-details/?pwid=96 Gou Wf, Ang XF, Shen DF, Zhao S, Liu YP, Sun HZ,et al.,The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy. Oncotarget. 2015; 6(23):19841. https://doi.org/10.18632/oncotarget.3734
